← FDA DRUG APPROVALS

FDA ANDA · ANDA203760

ALBUTEROL SULFATE

Sponsor: PADAGIS US

APPLICATION
ANDA203760
TYPE
ANDA
ORIGINAL APPROVAL
2020-02-24
LATEST ACTION
2020-09-29
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
AEROSOL, METERED
MARKETING STATUS
Prescription

Products

ALBUTEROL SULFATEPrescription
ALBUTEROL SULFATE EQ 0.09MG BASE/INH · AEROSOL, METERED · INHALATION

Approval history

2020-09-29Manufacturing (CMC) · Supplement 2 · unknownAP
2020-02-24UNKNOWN · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →